Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,935,700 papers from all fields of science
Search
Sign In
Create Free Account
Pneumonitis
Known as:
inflammation lung
, Inflammations, Lung
, Inflammation, Pulmonary
Expand
Inflammation of the lungs. This may be caused by disease, infection, radiation therapy, allergy, or irritation of lung tissue by inhaled substances.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Aspiration pneumonitis
Chest
Inflammation
Lung
Expand
Broader (1)
Lung diseases
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Protection from lipopolysaccharide-induced lung injury by augmentation of airway S-nitrosothiols.
H. E. Marshall
,
E. Potts
,
Z. T. Kelleher
,
Jonathan S. Stamler
,
W. M. Foster
,
R. Auten
American Journal of Respiratory and Critical Care…
2009
Corpus ID: 25053482
RATIONALE S-Nitrosothiols (SNO) inhibit immune activation of the respiratory epithelium and airway SNO levels are decreased in…
Expand
Review
1996
Review
1996
The alphabet soup revisited: the chronic interstitial pneumonias in the 1990s.
H. McAdams
,
M. Rosado-de-Christenson
,
W. D. Wehunt
,
N. Fishback
Radiographics
1996
Corpus ID: 7289458
Liebow classified the idiopathic interstitial pneumonias as usual (UIP), desquamative (DIP), bronchiolitis obliterans (BIP…
Expand
1987
1987
Acquisition of peroxidase activity by rat alveolar macrophages during pulmonary inflammation.
J. Shellito
,
M. Sniezek
,
M. Warnock
American Journal of Pathology
1987
Corpus ID: 38263879
The authors investigated the ability of rat alveolar macrophages to acquire peroxidase activity in the course of pulmonary…
Expand
1986
1986
Ciprofloxacin in the treatment of pneumonia
J. Ernst
,
E. Sy
,
H. Colon-Lucca
,
N. Sandhu
,
T. Rallos
,
V. Lorian
Antimicrobial Agents and Chemotherapy
1986
Corpus ID: 11253303
The use of ciprofloxacin as the sole agent in the treatment of 25 patients with pneumonias caused by susceptible organisms…
Expand
Review
1983
Review
1983
Pneumonia Due to the Pittsburgh Pneumonia Agent: New Clinical Perspective with a Review of the Literature
R. Muder
,
V. Yu
,
J. Zuravleff
Medicine
1983
Corpus ID: 21994222
We review the current knowledge concerning this newly recognized pathogen, Pittsburgh pneumonia agent (PPA), and present a new…
Expand
1979
1979
Legionnaires' disease in pneumonia patients in Iowa. A retrospective seroepidemiologic study, 1972-1977.
E. Renner
,
C. Helms
,
+5 authors
W. Hausler
Annals of Internal Medicine
1979
Corpus ID: 37423265
The frequency of Legionnaires' disease among 586 cases of pneumonia that occurred in Iowa between fiscal years 1972 and 1977 was…
Expand
1977
1977
Comparison of amikacin and tobramycin in the treatment of infection in patients with cancer.
R. Feld
,
M. Valdivieso
,
G. Bodey
,
V. Rodriguez
Journal of Infectious Diseases
1977
Corpus ID: 3252555
Two new aminoglycoside antibiotics, tobramycin and amikacin, were compared in a randomized study of the treatment of infections…
Expand
Highly Cited
1966
Highly Cited
1966
Desquamative interstitial pneumonia.
E. Gaensler
,
A. Goff
,
C. Prowse
New England Journal of Medicine
1966
Corpus ID: 46371893
Highly Cited
1965
Highly Cited
1965
SUCCESSFUL TREATMENT OF PNEUMOCYSTIS CARINII PNEUMONITIS IN A PATIENT WITH CONGENITAL HYPOGAMMAGLOBULINEMIA.
J. Robbins
,
R. Miller
,
V. Areán
,
H. Pearson
New England Journal of Medicine
1965
Corpus ID: 6399392
PNEUMOCYSTIS CARINII is established as a pathogen for the susceptible human host1 and in the laboratory animal2 and is the…
Expand
1956
1956
Severe toxic effects from aminophylline and theophylline suppositories in children.
A. Nolke
Journal of the American Medical Association
1956
Corpus ID: 45436425
• Ten children with asthma and three with other respiratory disorders were treated with aminophylline in the form of…
Expand